Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Accel Entertainment | ACEL | May 24, 2024 | 9.61 | +0.95 |
Accelerate Diagnostics | AXDX | May 24, 2024 | 1.38 | +8.24 |
Accenture A | ACN | May 24, 2024 | 300.99 | -1.61 |
Acco Brands | ACCO | May 24, 2024 | 5.04 | 0.00 |
Accolade | ACCD | May 24, 2024 | 7.37 | +2.79 |
Accuray | ARAY | May 24, 2024 | 1.51 | +1.34 |
Ace Global Business Acquisition | ACBA | May 24, 2024 | 12.03 | 0.00 |
Ace Global Business Acquisition Unit | ACBAU | May 24, 2024 | 12.00 | 0.00 |
Acelyrin | SLRN | May 24, 2024 | 4.13 | -2.13 |
Achieve Life Sciences | ACHV | May 24, 2024 | 5.41 | 0.00 |
Achilles Therapeutics ADR | ACHL | May 24, 2024 | 0.91 | +1.53 |
ACI Worldwide | ACIW | May 24, 2024 | 35.42 | -0.14 |
Aclarion | ACON | May 24, 2024 | 0.31 | -3.55 |
Aclaris Therapeutics | ACRS | May 24, 2024 | 1.11 | -5.93 |
ACM Research A | ACMR | May 24, 2024 | 22.56 | +1.26 |
Acme United | ACU | May 24, 2024 | 39.35 | -0.20 |
ACNB | ACNB | May 24, 2024 | 31.99 | -0.62 |
ACRES Commercial Realty | ACR | May 24, 2024 | 12.81 | -1.39 |
ACRES Commercial Realty C Pref | ACR-C | May 24, 2024 | 24.58 | +0.28 |
ACRES Commercial Realty D Pref | ACR-D | May 24, 2024 | 20.76 | +0.05 |
Acrivon Therapeutics | ACRV | May 24, 2024 | 7.95 | -1.97 |
Actelis Networks | ASNS | May 24, 2024 | 0.55 | -0.04 |
Actinium Pharmaceuticals | ATNM | May 24, 2024 | 8.50 | +0.95 |
Active Bear ETF | HDGE | May 24, 2024 | 20.51 | -0.34 |
Active U.S. Real Estate Powershares | PSR | May 24, 2024 | 83.56 | -0.04 |
Acuity Brands | AYI | May 24, 2024 | 262.88 | 0.00 |
Acumen Pharmaceuticals | ABOS | May 24, 2024 | 3.40 | 0.00 |
Acurx Pharmaceuticals | ACXP | May 24, 2024 | 2.51 | -3.83 |
Acushnet | GOLF | May 24, 2024 | 64.45 | +3.19 |
Acutus Medical | AFIB | May 24, 2024 | 0.12 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.